| Literature DB >> 36131825 |
Hiba Abbas Widatalla1, Layla Fathi Yassin2, Ayat Ahmed Alrasheid3, Shimaa Abdel Rahman Ahmed2, Marvit Osman Widdatallah1, Sahar Hussein Eltilib1, Alaa Abdulmoneim Mohamed4.
Abstract
The use of nanoparticles in medicine, nanomedicine, is very important to diagnose and treat diseases; among the various metallic nanoparticles, silver nanoparticles (AgNPs) are very popular due to their physical, chemical, and biological properties, encompassing a range of activities such as antiviral, antifungal, anti-inflammatory, and anticancer activities. In this study, the synthesis of AgNPs was conducted by the use of a nontoxic, ecofriendly method. Green tea (GT) leaf extract was used as a reducing agent to convert silver ions into free AgNPs. The UV-vis spectrum showed a peak at 410 nm, confirming the presence of AgNPs. A Fourier-transform infrared (FTIR) analysis of the GT extract and GT AgNPs display spectra that is identical to those of polyphenols, polysaccharides, and proteins. All the vibrational peaks in the GT extract spectrum were shifted in the AgNP spectrum, becoming narrower after the encapsulation of nanoparticles. The scanning electron microscopy (SEM) images confirm the presence of AgNPs with different sizes, ranging from 15 to 33 nm. Furthermore, the antibacterial activity of the synthesized AgNPs in three different concentrations (10, 20, and 50 mg ml-1) showed appreciable inhibition of bacterial growth against Staphylococcus aureus and Klebsiella sp. From the above findings, we can recommend the use of AgNPs from GT leaf extracts as an antimicrobial agent to treat chronic infections. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36131825 PMCID: PMC9419201 DOI: 10.1039/d1na00509j
Source DB: PubMed Journal: Nanoscale Adv ISSN: 2516-0230
Fig. 1Preliminary conformation of GT AgNP synthesis. GT extract (A) GT AgNPs (B).
Fig. 2UV spectrum of AgNP synthesized from GT extract.
Fig. 3IR spectra of GT extract and GT AgNPs.
Fig. 4SEM image of the synthesized nanoparticles.
Fig. 5STD against S. aureus (A), GT AgNPs against S. aureus (B).
Fig. 6STD against Klebsiella spp. (A), GT AgNPs against Klebsiella spp. (B).
Antimicrobial activity of GT AgNPs
| Zone of Inhibition in mm | ||
|---|---|---|
|
|
| |
|
| ||
| 20 | 10 | 11 |
| 10 | 8 | 8 |
| 5 | 9 | 10 |
|
| ||
| Ciprofloxacin (5 mcg) | 26 | 32 |